日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Human hippocampal neurogenesis in adulthood, ageing and Alzheimer's disease

成年期、衰老和阿尔茨海默病中的人类海马神经发生

Disouky, Ahmed; Sanborn, Mark A; Sabitha, K R; Mostafa, Mostafa M; Ayala, Ivan Alejandro; Bennett, David A; Lu, Yisha; Zhou, Yi; Keene, C Dirk; Weintraub, Sandra; Gefen, Tamar; Mesulam, M-Marsel; Geula, Changiz; Maienschein-Cline, Mark; Rehman, Jalees; Lazarov, Orly

Limited thermal tolerance in tropical insects and its genomic signature

热带昆虫有限的耐热性及其基因组特征

Holzmann, Kim L; Schmitzer, Thomas; Abels, Antonia; Čorkalo, Marko; Mitesser, Oliver; Kortmann, Mareike; Alonso-Alonso, Pedro; Correa-Carmona, Yenny; Pinos, Andrea; Yon, Felipe; Alvarado, Mabel; Forsyth, Adrian; Lopera-Toro, Alejandro; Brehm, Gunnar; Keller, Alexander; Otieno, Mark; Steffan-Dewenter, Ingolf; Peters, Marcell K

The oncogenome of the domestic cat

家猫的癌基因组

Francis, Bailey A; Ludwig, Latasha; He, Chang; Dobromylskyj, Melanie; Bertram, Christof A; Aupperle-Lellbach, Heike; Wong, Hannah; Foster, Aiden P; Arends, Mark J; Suárez-Bonnet, Alejandro; Priestnall, Simon L; Tatiersky, Laetitia; Castillo-Alcala, Fernanda; Rupp, Angie; Khachadoorian, Arlene; Parlak, Eda; Inglebert, Marine; Umamaheswaran, Shevaniee; Cheema, Saamin; Del Castillo Velasco-Herrera, Martin; Wong, Kim; Vermes, Ian C; Billington, Jamie; Rottenberg, Sven; Wood, Geoffrey A; Adams, David J; van der Weyden, Louise

Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1(Glu280Ala) mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial

在哥伦比亚,一项针对认知功能正常的、携带PSEN1(Glu280Ala)突变且有常染色体显性遗传阿尔茨海默病风险的人群的克雷尼珠单抗安全性和有效性研究(API ADAD Colombia试验):一项2期随机、双盲、安慰剂对照试验

Tariot, Pierre N; Lopera, Francisco S; Ríos-Romenets, Silvia; Sink, Kaycee M; Giraldo-Chica, Margarita; Acosta-Baena, Natalia; Villegas, Gustavo; Espinosa, Alejandro; Castaño, Marisol Londoño; Muñoz, Claudia; Ospina, Paula; Bocanegra, Yamile; Tirado, Victoria; Henao, Eliana; Cardona, Eugenia; Luna, Ernesto; Lopez, Hugo; Sánchez, Gregorio; Collazos, Mario Muñoz; Alvarez, Sergio; Aguillón, David; Hu, Nan; Clayton, David; Bittner, Tobias; Schneider, Andres; Dolton, Michael; Poon, Victor; Nguyen, Jonas; Thomas, Ronald G; Schneider, Lon S; Chen, Kewei; Su, Yi; Alexander, Robert C; Quiroz, Yakeel T; Cai, Yuqi; Xu, Yi Ran; Ostaszewski, Beth; Selkoe, Dennis J; Ashton, Nicholas J; Denkinger, Marisa N; Jakimovich, Laura J; Doody, Rachelle S; Langbaum, Jessica B; Reiman, Eric M

BRUIN CLL-313: Randomized Phase III Trial of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

BRUIN CLL-313:一项随机III期临床试验,比较吡托布替尼与苯达莫司汀联合利妥昔单抗治疗未经治疗的慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者的疗效。

Jurczak, Wojciech; Kwiatek, Michal; Czyz, Jaroslaw; Roberto de Mattos, Ederson; Eom, Ki-Seong; Egle, Alexander; Panovska, Anna; Popova, Zhanet Grudeva; Shih, Hsuan-Jen; Casado Montero, Luis Felipe; Sportoletti, Paolo; Hua, Vu Minh; D'Olimpio, James T; Iida, Shinsuke; Ito, Rodrigo; Bao, Katherine; Fink, Anne; Su, Weiji; Ruppert, Amy S; Levy, Alejandro; Wrobel, Tomasz

Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

吡托布替尼与伊布替尼治疗初治及复发/难治性慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的比较

Woyach, Jennifer A; Qiu, Lugui; Grosicki, Sebastian; Wrobel, Tomasz; Capra, Marcelo; Czyz, Jaroslaw; Yi, Shuhua; Eom, Ki-Seong; Panovská, Anna; Jurczak, Wojciech; Laribi, Kamel; Jacobasch, Lutz; Baker, Ross; Agajanian, Richy; Berkovits, Alejandro; Özcan, Muhit; Lepretre, Stéphane; Coombs, Catherine C; Cramer, Paula; Lewis, Katharine L; Hill, Marisa; Bao, Katherine; Bian, Yuanyuan; De Batista Ribeiro, Silvia Ramalho; Bhandari, Naleen Raj; Ruppert, Amy S; Leow, Ching Ching; Wierda, William G

LncRNA PVT1 in human cancers: genomic complexity, isoforms, functional elements, mechanism of action, subcellular localization and possible role as a therapeutic target

人类癌症中的长链非编码RNA PVT1:基因组复杂性、异构体、功能元件、作用机制、亚细胞定位及其作为潜在治疗靶点的作用

Li, Chen; Lagunas-Rangel, Francisco Alejandro; Du, Lutao; Sun, Chengxi; Schiöth, Helgi B

Epigenetic and Transcriptional Programs Define Osteosarcoma Subtypes and Establish Targetable Vulnerabilities.

表观遗传和转录程序决定骨肉瘤亚型并建立可靶向的脆弱性。

López-Fuentes Eunice, Clugston Andrew S, Lee Alex G, Sayles Leanne C, Sorensen Natalie, Pons Ventura Maria V, Leung Stanley G, Dinh Truc, Breese Marcus R, Sweet-Cordero E Alejandro

Pertpy: an end-to-end framework for perturbation analysis

Pertpy:一个端到端的扰动分析框架

Heumos, Lukas; Ji, Yuge; May, Lilly; Green, Tessa D; Peidli, Stefan; Zhang, Xinyue; Wu, Xichen; Ostner, Johannes; Schumacher, Antonia; Hrovatin, Karin; Müller, Michaela; Chong, Faye; Sturm, Gregor; Tejada, Alejandro; Dann, Emma; Dong, Mingze; Pinto, Gonçalo; Bahrami, Mojtaba; Gold, Ilan; Rybakov, Sergei; Namsaraeva, Altana; Moinfar, Amir Ali; Zheng, Zihe; Roellin, Eljas; Mekki, Isra; Sander, Chris; Lotfollahi, Mohammad; Schiller, Herbert B; Theis, Fabian J

Histone acetylation-dependent clustering of BRD2 instructs transcription dynamics

组蛋白乙酰化依赖的BRD2聚集调控转录动态

Erdogdu, Niyazi Umut; Guhathakurta, Sukanya; Oellers, Ronald; Shvedunova, Maria; Morin, Jose A; Patrick, Eric M; Seyfferth, Janine; Deboutte, Ward; Gomez-Auli, Alejandro; Mittler, Gerhard; Cissé, Ibrahim I; Akhtar, Asifa